AREES – Lazhar Bounafa, Director General – Algeria
The Director General for the newly created National Agency for Healthcare Equipment and Management of Health…
The National Agency for Healthcare Equipment and Management of Health Infrastructures (AREES) is Delegate project manager to manage, on behalf of the state, transactions or services contributing to the realization of health sector investment projects, and secondly, to supervise provision of health equipment based on a list established by the Ministry of Health.
The Director General for the newly created National Agency for Healthcare Equipment and Management of Health…
Switzerland is a crucial country for MSD’s global network, employing over 1000 people in local, regional, and…
The top 10 most-read interviews on PharmaBoardroom in 2020 represents the broad geographic scope we have had in the…
Dr Remo Gujer gives an overview of the BMS footprint in Switzerland and Austria, the ongoing integration of legacy…
Brad Campbell, president and COO of US rare disease specialist Amicus, talks domestic and global product launches,…
Hours after President Biden was inaugurated on Tuesday 19th January 2021, Dr Janet Woodcock was named as acting…
Alessandro Riva, MD joined biotech Ichnos Sciences as its founding CEO in 2019, leaving behind a storied career in…
COVID-19 has highlighted the importance of secure regional pharma supply chains across the globe, not least in…
With upcoming EU regulation poised to have a massive impact on ethical regulations around AI in Europe, Bayer Head…
Clinerion, a leader in real-world data solutions, is helping bring medical data informatics to the life sciences…
David H. Crean, managing director for Objective Capital Partners, provides insights on US innovation and long term…
Kevin Rufang Huang, president and founder of the Chinese Organization for Rare Disorders (CORD), outlines the…
Following on from our list of the overall top 10 companies in the Saudi Arabian pharma market, here PharmaBoardroom…
The collaboration between BioNTech and Pfizer on a COVID-19 vaccine candidate based on mRNA technology continues…
The latest from Spanish pharma, including the wide swathe of COVID-19 syringes, vaccines, masks, and tests being…
While cell and gene therapies are all the rage now, a little known fact is that the world’s first approved gene…
Sissel Lønning Andresen explains how Pfizer Norway has been a pioneer of digital communication channels for years,…
Roche Diagnostics Norway’s Daniel Malarek discusses the resurgence of diagnostics in the wake of the COVID-19…
Prof Dr Jürg Utzinger of the Swiss Tropical and Public Health Institute (Swiss TPH) outlines the organisation’s…
David H. Crean summarizes the recent 39th annual J.P. Morgan Healthcare Conference 2021 that was held in a virtual…
Dr Chris Martin, CEO and co-founder of Swiss-headquartered antibody-drug conjugate cancer company, ADC…
Sanofi CEO Paul Hudson ignited a heated debate around vaccine nationalism earlier this year when he suggested that…
The latest news from Indian pharma, including a 200 percent boost for the country’s pharmaceutical industry in…
With Rare Disease Day falling on 28 February, PharmaBoardroom dedicates this month to exploring the global rare…
Joe Lewis outlines the key concerns of Deloitte’s pharma clients around manufacturing and supply chain operations…
In a recent conversation with PharmaBoardroom, Prof. Hisham Bin Saad Al-Jadhey, CEO of the Saudi Food and Drug…
Novo Nordisk Switzerland’s Mads Stoustrup introduces the affiliate’s remarkable process on bringing innovative…
A roundup of some of the most important recent news from German pharma, including state honours for the founders of…
Redalpine Venture Partners’ Dr Michael Sidler highlights some of the key trends in the European biotech VC…
In his latest piece on Alzheimer’s Disease (AD) drug Aducanumab’s winding journey to market, Dr Neil Cashman…
Marcel Plattner, president of Swiss industry association vips discusses pricing, market access and innovation, as…
A Tale of Two Americas The US stands as the biopharma innovation champion of the world, a global leader on nearly…
DHL’s Larry St Onge outlines how the logistics giant adapted to the COVID-19 pandemic in 2020, the unprecedented…
Dan Leonard, president and CEO of the Association for Accessible Medicines (AAM) since August 2020, outlines his…
A rundown of five things to know about the USD 8.2 billion Saudi pharma market, including the impact of ‘Vision…
The latest from healthcare and the life sciences in Latin America, including the most recent wave of Indian pharma…
Alfasigma Switzerland’s Dr Tytus Litynski introduces the Italian firm’s diversified portfolio of both Rx drugs…
Eric ten Kate, VP for Global Life Science at logistics and distribution firm Agility, highlights how the company…
The latest from Italian pharma, including the foreign minister’s plea for delivering on COVID-19 vaccine…
The latest LatAm pharma news, including COVID-19 vaccine rollouts in Colombia, Brazil, and Mexico as well as legal…
On 7 October 2020, the 2020 Nobel Prize in Chemistry was jointly awarded to Emmanuelle Charpentier and Jennifer A.…
Niklas Hedberg outlines the role of EUnetHTA as both a network and project built up of national HTAs in Europe, the…
Christian Probst gives an overview of GSK Norway’s broad portfolio, market access hurdles, and the importance of…
Pius Zängerle of curafutura, one of the two largest Swiss health insurers’ associations, explains the unique…
Mera Pharma’s Khalid Saleh introduces the Swiss-headquartered but MENA-focused company, how it plans to expand…
Toshio Fujimoto, MBA, MD of Japan’s Shonan Health Innovation Park looks at how a technology developed in Japan…
Dan Schneider discusses the continuing Norwegian identity of Photocure, despite its increasingly global footprint,…
The latest news from Russian pharma, including Biocad’s ramping up of Sputnik V COVID-19 vaccine manufacturing,…
A roundup of the latest from Chinese pharma, including Green Valley’s upcoming US trial for an…
The EMA’s Head of Advanced Therapies Dr Ana Hidalgo-Simon outlines Europe’s evolving regulatory framework for…
The latest news from Russian pharma and healthcare including a big funding injection for primary care up to 2025,…
Pierrre Morneau of Takeda Switzerland explains the therapeutic areas at the core of the company, equitable access,…
Thomas A. Tóth von Kiskér, longstanding CEO of Tillotts Pharma AG, a Switzerland-based specialty pharma player…
CEO Ellen Cathrine Andersen introduces Norwegian firm Epiguard’s ‘Epishuttle’ technology for transporting…
Founded in 1950, EMS is one of the top two domestic pharma companies in Brazil. As a key player in the largest and…
RemeGen, a low-profile Chinese biotech company based in Yantai city in the coastal Shandong province, around nine…
Rubens Hannun, president of the Arab Brazilian Chamber of Commerce, discusses the commercial relationship between…
Market access and pricing expert Barbara Jaszewski outlines the issues inherent in the USA importing drugs from…
AbbVie Switzerland’s Jon Helsdingen outlines how he has led the Swiss affiliate through a full scale office…
In an exclusive and wide-ranging interview, Harjit Gill outlines the work of pan-Asia-Pacific medtech association…
ASLAN Pharmaceuticals is a clinical-stage immunology-focused biopharmaceutical company. CEO Dr Carl Firth reveals…
This article forms part of Healthcare & Life Sciences Review: Switzerland February 2021, a comprehensive…
Professor Nicolaus Kröger, president of the European Society for Blood and Marrow Transplantation (EBMT)…
Clint Sharples, CEO of Heritage Cannabis, gives a potted history of the medical cannabis industry in Canada, its…
When Abdi Ibrahim acquired a 28.5 percent stake in Swiss biotech OM Pharma in September 2020, it represented a…
Although Switzerland is ahead of many of its competitors in Europe on levels of healthcare innovation, one…
Thomas Cueni of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) highlights…
hystrix medical is an online contracting marketplace for medical devices and replenishing/repeat purchase products…
Dr Thomas D. Madden, CEO and founder of Acuitas Therapeutics, shares the story behind their involvement in Pfizer…
The story of how British doctor Edward Jenner serendipitously discovered a way to inoculate people against smallpox…
One of the largest domestic pharma companies in China (ranking number one from 2014 to 2019), Yangtze River…
While Big Pharma companies like Pfizer, Janssen and AstraZeneca, have grabbed the headlines over the past year for…
2020 has been eventful – perhaps the understatement of the year – but despite the novel coronavirus being…
Following a recent capital injection of USD 67 million, Chinese biotech EdiGene is set to advance its pipeline in…
Dr Liang Schweizer introduces immunotherapy-focused biotech HiFiBiO Therapeutics, the main advantages of the…
Merck VP for Global Market Access & Pricing Strategic Planning Marco Rauland examines the trend of…
Dr Gideon Ho, co-founder and CEO of HistoIndex, shares the story of the company’s establishment in 2010, their…
Following on from our profile on five of the most promising clinical-stage biotech companies developing orphan…
Biotech veteran Brian O’Callaghan introduces ObsEva – a Swiss-based firm focused on women’s health –, his…
The latest news from pharma and healthcare in Latin America, including funding and logistics challenges in national…
Lance Little, managing director for Roche Diagnostics in Asia Pacific and board member of the Asia Pacific Medical…
Japanese pharma companies are already far lower-profile than their occidental counterparts but an even lesser-known…
HiFiBiO Therapeutics cofounder, CEO and CSO Dr Liang Schweizer fits the profile of a Chinese biotech CEO to a T:…
The Brazilian pharma market outperformed the Latin American average in Q1 of 2020 with a growth of 8.2 percent in…
On 15 November 2020, the world’s largest trade deal in terms of GDP – the Regional Comprehensive Economic…
Advances in cell and gene therapies (CGT) are credited with thoroughly transforming medicinal science and creating…
The CEO & President of CDMO CordenPharma, Dr Michael Quirmbach, delves into the contract manufacturing…
Small in terms of market size and without the historic life sciences footprint of neighbouring Sweden and Denmark,…
With several COVID-19 vaccines gaining regulatory approval across the world in record time, a spotlight has been…
Laurent Massuyeau introduces Swiss biosimilar commercialisation specialist iQone healthcare, why it made sense to…
In November 2020, after months of delay caused by COVID-19 disruptions and a US antitrust roadblock, Mylan and…
Alejandro Mora, Ferrer’s country manager for Central America & Caribbean, discusses the complexity of the…
Dennis Hens, the Dutch CEO of Norwegian neuro-opthalmology device player Bulbitech, outlines the company’s…
The latest from Mexico’s fight against COVID-19, including news of vaccine tourism into the US, how China’s…
Dr Valters Bolevics, director general of the Association of International Research-based Pharmaceuticals…
Scientists have come together in an unparalleled worldwide collaboration and sharing of data to advance a COVID-19…
Stephen J. Ubl, president and CEO of PhRMA, outlines the unprecedented collaboration and speed with which the…
Medtech industry veteran Sanjay Prabhakaran outlines the footprint and strategy of women’s health specialist…
MSD’s Ashish Pal describes how he led the Singapore, Malaysia, and Brunei cluster through a challenging 2020; the…
The Top 15 pharmaceutical companies in the Central America and Caribbean (CENCA) market list is dominated by…
Bayer’s Michael Levy casts his eye over the implications of the advent of cell and gene therapies on…
Merck Healthcare’s newly appointed Global Head of Business innovation, Renée C. Amundsen, highlights the…
PharmaBoardroom had the pleasure of interviewing HitGen chairman & CEO Dr Jin LI in July regarding the…
Andrea Emilio Rizzoli of the Dalle Molle Institute for Artificial Intelligence, among the top 10 in the world in…
While 2020 may have seemed like the year the world stood still for many, the pharma industry went into overdrive,…
Dr Ann Aerts, head of the Novartis Foundation, highlights how the COVID-19 crisis has thrust artificial…
The latest from Chinese pharma, including domestic regulatory approval for Sinopharm’s COVID-19 vaccine, how…
A roundup of the latest from the Middle East & Africa region, including Turkey’s debt to US pharma; deals…
Genald Senior, general manager for Leterago, the leading pharma distributor in the Dominican Republic, discusses…
Writing in the March edition of DIA’s Global Forum magazine, EMD Serono’s Ana Padua outlines the findings…
Nawal Roy of global digital health platform Holmusk which aims to establish data as a core utility to the treatment…
Kevin Zou highlights Novartis Oncology’s footprint and priorities in the diverse Asia-Pacific region, the…
Alan Knox of Primex Pharmaceuticals explains how the COVID-19 pandemic has thrust the anaesthesia field back into…
AAM President Dan Leonard highlights the findings of the association’s most recent report and re-states the value…
Since China first announced its ground-breaking volume-based procurement (VBP) pilot program to reduce drug…
While perhaps not as lucrative or – prior to COVID-19 – as attention-grabbing – as other areas of the…
A roundup of some of the most important recent stories from Italian pharma, including an in-depth interview with…
Thomas Bohn outlines how the life sciences industry in Western Switzerland has continued to perform well despite…
The AAM’s Dan Leonard highlights the savings impact that generic and biosimilar have on US healthcare today and…
Last Wednesday, the lower chamber of the Mexican Congress approved a bill that would legalise recreational…
2020 was a challenging year globally, but one in which the importance of the healthcare and life sciences sector…
With a series of reorganization initiatives, new leaders at the helm and exciting acquisitions, Novartis Oncology…
Pharma industry insiders view vaccines as one of the most challenging products to manufacture, fundamentally due to…
The latest from French pharma where Sanofi has inked a deal to produce 125 million doses of Pfizer’s COVID-19…
Filip Standaert outlines the significance of the Nordic cluster to J&J’s medical device operations in Europe,…
Alvotech – the biosimilars arm of Icelandic-headquartered generics player Alvogen – is positioning itself for…
Dr Johan Van Hoof, global therapeutic area head of vaccines for Janssen, shares his extensive career experience in…
As the global pharmaceutical industry continues to grow, so have opportunities for service providers. Over the last…
Six of the top ten companies in the Brazilian pharma market are domestic.* Read on for an introduction to some of…
Stefan Hendriks, Global Head of Novartis Oncology’s Cell & Gene division outlines the company’s progression…
Brent Ragans of Ferring Pharmaceuticals US discusses the effects of the COVID-19 pandemic on the company’s…
Dr Haijun Dong, recently appointed CEO of BioDuro-Sundia, shares his priorities for the newly merged entity, one of…
Emerging cell and gene therapies herald immense clinical value for patients, society, and healthcare systems:…
Zogenix’s Dr Stephen Farr shares his remarkable career journey from academia to industry, the company’s…
Tatsuya Kaihara, head of US operations for Japanese eyecare specialist Santen, describes his excitement at bringing…
The latest from Chinese pharma, including a new deal between AstraZeneca and Junshi Biosciences; Innoforce and…
PhRMA’s Stephen J. Ubl outlines two ways in which the new US presidency can help lower healthcare costs and why…
Many countries have struggled to adapt to the shift to remote working and digital communication brought about by…
Sandoz Switzerland’s Jan Tangermann highlights the importance of the Swiss affiliate to the global group and how…
South African firm Aspen has inked a deal with Johnson & Johnson for the technical transfer and proposed…
Although the COVID-19 pandemic and the subsequent rush to develop diagnostics, therapeutics, and vaccines dominated…
German biotech BioNTech has been thrust into the global spotlight thanks to its collaboration with global giant…
Novartis Oncology’s Emanuele Ostuni (lead author) and Karin Blumer draw on their experience commercialising CAR-T…
Dr Nicolas Fischer introduces Light Chain Bioscience, a Swiss biotech company focusing on the discovery and…
Pfizer Switzerland’s Sabine Bruckner discusses Switzerland’s historic and continuing importance to Pfizer,…
AbbVie Norway’s Kirsti Nyhus discusses access challenges in the Norwegian market for innovative drugs, the…
The US heads for three leading international mid-cap innovators – Japanese firms Eisai and Kyowa Kirin and Danish…
Singapore’s Institute of Mental Health offers a comprehensive range of psychiatric, rehabilitative, and…
The EFPIA’s Nathalie Moll outlines the significance of Europe’s Beating Cancer Plan to cancer patients in…
A trained physician with several years of practice under her belt, Katharina Gasser then moved into clinical…
After a year of growth and acquisitions, 125-year-old German generics manufacturer STADA is showing a willingness…
The latest COVID-19 vaccine news from the Middle East & Africa (MEA) region, including the fallout from…
Novo Nordisk Singapore’s Praful Chakkarwar explains how he leverages his experience in a range of geographies…
The journey of EUnetHTA began back in 2004, when the European Commission and Council of Minsters requested the…
Belgian champion UCB’s global manufacturing head, Jacques Marbehant, talks candidly about managing a broad…
As part of the Federal Department of Home Affairs, the Federal Office of Public Health (FOPH) is responsible for…
One of the more intriguing aspects about the new wave of cell and gene therapies (CGT) coming onstream is that they…
Dipharma SA is a Swiss specialty pharmaceutical company, developing improved generics medicines for rare metabolic…
The Association of Representatives, Agents and Pharmaceutical Producers (ARAPF), represents 65 companies in the…
After an illustrious career in oncology R&D, contributing greatly to the development of cutting-edge cancer…
Professor Susan M. Gasser, now director and group leader emeritus of the Friedrich Miescher Institute for…
Japanese medtech player Terumo’s APAC lead Probir Das outlines the company’s 100-year commitment to innovation,…
CCO Anil Okay introduces how Alvotech’s focus on biosimilars, comprehensive platform, differentiated portfolio…
The first day of March 2013 also marked a first for GW Pharmaceuticals. On that day, the British biopharmaceutical…
Dr Choong May Ling, Mimi, CEO of Singapore’s Health Sciences Authority (HSA), one of the leading regulatory…
In an exclusive interview, Jean-Paul Clozel explains Idorsia’s unique value proposition as a biotech focused…
Innosuisse CEO Annalise Eggimann presents the organisation’s renewed mandate as the main Swiss innovation…
The global rush to secure access to COVID-19 vaccines has led to accusations that richer countries are hoarding…
Photodynamic therapy (PDT) firm Photocure is probably Norway’s most significant recent international healthcare…
The latest from Southeast Asian pharma, including soaring output in Singapore, tax breaks for research in…
After five years with Takeda heading up the Japan-headquartered pharma company’s US business, following the…
While great strides in gender diversity has been made within healthcare boardrooms and leadership teams globally,…
Founded by Toyoji Naito in December 1941, in just under 80 years, Eisai has become a leading global biopharma…
Epidemiologist John-Arne Røttingen has had a long and distinguished career in both academia and industry,…
Charles Chen of Taiwanese firm Medigen Vaccines Biologics Corp (MVC) shares his career journey, the company’s…
Vaccines have been touted – and rightly so – as the most cost-effective health intervention after access to…
Norway has long held a strong international position in neuroscience and is home to Professors May-Britt and Edvard…
A roundup of the latest stories from French pharma, including the progress of Sanofi’s COVID-19 vaccine, how…
After 15 years as director at the Friedrich Miescher Institute for Biomedical Research (FMI) (2004-2019) and even…
Equality has long been a deeply held ideal in Norway, where the concept of allemannsretten – the legal right to…
As the most important pharma hub in its region, and one of the most important globally, many companies look to…
Thomas F. Schmidt, country manager of Roche Pharma in its home market of Switzerland discusses adjusting to his…
During the FT Global Pharmaceutical and Biotechnology Conference earlier this week, four Big Pharma and biotech…
Rare disease – defined in the US as a disease with a maximum patient population of 200,000 – is perhaps the…
COVID-19 has drawn global attention to the sorry state of funding and R&D investment in vaccine development and…
Genomic medicine expert Professor Thomas D. Szucs explains what ignited his interest in the field and how payers…
Ipsen CEO David Loew took aim at the lip service often paid to the notion of ‘patient-centricity’ in pharma in…
The ascent of cell and gene therapies (CGT) is commonly regarded as one of the momentous turning points in the…
At USD 150 billion, Asia-Pacific is home to the world’s second largest medtech market and, with a CAGR of nine…
Bayer’s Dr Vincent Ruland highlights his career trajectory from medical doctor to pharma country manager; the…
Writing in the February edition of DIA’s Global Forum magazine, Thomas Kühler of Sanofi R&D looks at the…
Speaking exclusively to PharmaBoardroom, Prof. Hisham Bin Saad Al-Jadhey, CEO of the Saudi Food and Drug Authority…
The latest from Chinese pharma, including a drop in share prices for Chinese vaccine firms in the wake of…
Bandar Reda outlines the evolution of the trading relationship between the UK and the Arab world, the role of the…
The SGC’s Dr Tim Philippi introduces the sizeable Singaporean-German trading relationship and the importance…
After a transformative 2020, Shawview Consulting’s Brendan Shaw looks into his crystal ball and makes five…
Rare disease patient advocate Monica Weldon outlines some of the ethical conundrums around embryonic gene editing.…
From almost being de-listed by the NASDAQ stock index in 2018 due to poor financial performance, US vaccine firm…
Certara’s Ulrich Neumann examines some of the major US market access trends of the past few years, including…
Nerum Pharmaceuticals, a Switzerland-based start-up, is supplying high-grade cannabis products to nine countries…
Dr Thomas D. Madden, CEO and founder of Acuitas Therapeutics, shares the story behind their involvement in Pfizer…
On 25 November 2020, the European Commission adopted a Pharmaceutical Strategy for Europe with the stated aim of…
PharmaBoardroom highlights three of the most enterprising and dynamic pharma affiliate country managers working in…
During the FT Global Pharmaceutical and Biotechnology Conference last week, GSK global vaccines president Roger…
Giorgio Calderari, the chairman of Farma Industria Ticino, the association of chemical and pharmaceutical…
The latest from Italian pharma, including the government’s decision to make COVID-19 vaccines mandatory for all…
Toshio Fujimoto, MBA, MD of Japan’s Shonan Health Innovation Park highlights key takeaways from the BIOJapan 2020…
Writing in the February edition of DIA’s Global Forum magazine, Xu Wang of Novo Nordisk Pharma China and Xiaoxi…
The latest news from Middle East & North African pharma, including Pfizer’s transformation of its Saudi…
With Rare Disease Day coming up on February 28th, one of the leading organizations dedicated to serving affected…
In a wide-ranging interview CEO Bertrand Ducrey introduces Debiopharm’s unique business focus on drug…
Four companies (GSK, Pfizer, Sanofi, and MSD) together occupy over 80 percent of the global market for vaccines.…
Dr Maria T. Millan, president and CEO of the California Institute for Regenerative Medicine (CIRM), shares the…
In March 2018, German pharma player Boehringer Ingelheim (BI)‘s Consanas Rehabilitation and the Shanghai…
Eric Bouteiller examines the most recent update to China’s National Reimbursement Drug List, the positive impact…
When the European Medicines Agency (EMA) relocated from London to Amsterdam after the UK announced its decision to…
Anders Blanck of Lif, the trade association for the research-based Swedish pharmaceutical industry, outlines the…
Lorenzo Ambrosini of the Agire Foundation introduces the major new innovation projects underway in the…
While Switzerland has Europe’s second-highest proportion of women in the workforce, it trails global…
During the FT Global Pharmaceutical and Biotechnology Conference earlier this month, three industry leaders spoke…
Takeda USA’s Ramona Sequeira outlines her expanded role as president of global portfolio commercialization, the…
COVID-19 has necessitated enormous shifts in the way we live, work, and communicate with each other. Nowhere is…
The latest pharma news from the Asia-Pacific region, including upcoming IPOs for Prestige Biopharma and HH&L…
Janssen Norway’s Mario Klesse shares his first impressions of the Norwegian pharma market, his strategic…
Dr Philipp Diesinger and Dr Gabriell Máté outline why a data-driven approach can help optimise patient copay…
John-Arne Røttingen, CEO of The Research Council of Norway shares his career journey from academia to industry,…
Following the recent news of Remegen’s massive USD 515 million IPO in November 2020, we bring you profiles of…
On 25 November, the European Commission adopted a new strategy meant to, among others, allow Europe to cover its…
Writing in the March edition of DIA’s Global Forum magazine, Judith Glennie examines the findings of Health…
In a wide-ranging interview, Henrik Asmussen outlines his priorities for Amgen’s important Swiss affiliate,…